Bellevue Group’s Yarrow Bioscience YARW Stock Holding History
Bought
Maintained
Sold
Other funds holding YARW
SL
Bellevue Group's YARW Position: Q3 2026 in Review
Bellevue Group opened a new position in Yarrow Bioscience (YARW) in Q3 2026: 1,000,000 shares worth $22.5M. The stake represents 0.47% of the portfolio and ranks #49 among its holdings.
48 funds tracked by Wall St. Rank hold YARW as of Q3 2026.
- Bellevue Group held 1,000,000 shares of Yarrow Bioscience worth $22.5M as of Q3 2026.
- Yarrow Bioscience was a new Bellevue Group position in Q3 2026.
- Yarrow Bioscience made up 0.47% of Bellevue Group's portfolio in Q3 2026, its #49 holding.
- 48 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2026.
Based on Bellevue Group's 13F filing for Q3 2026, filed 16 Nov 2026.